Clinical Trials

Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)

Condition:   Asthma
Interventions:   Drug: Asmanex twisthaler;   Other: Placebo for Asmanex twisthaler
Sponsor:   Merck Sharp & Dohme Corp.
Terminated

Thu, 01 Mar 2007 12:00:00 EST

Efficacy and Safety of Two Dry Power Inhalers (DPIs) Used for the Application of Mometasone in the Treatment of Asthma

Condition:   Asthma
Interventions:   Device: OXIMAX;   Device: ASMANEX TWISTHALER
Sponsor:   Mantecorp Industria Quimica e Farmaceutica Ltd.
Completed

Fri, 11 Sep 2009 12:00:00 EDT

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)

Condition:   Asthma
Interventions:   Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 25 mcg;   Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 50 mcg;   Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 100 mcg;   Drug: Mometasone Furoate (MF) Dry Powder Inhaler (DPI), 100 mcg;   Drug: Placebo Metered Dose Inhaler (MDI);   Drug: Placebo Dry Powder Inhaler (DPI)
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Fri, 30 Dec 2011 12:00:00 EST

A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)

Condition:   Asthma
Interventions:   Drug: Formoterol Fumarate DPI;   Drug: Mometasone Furoate/Formoterol Fumarate MDI (ex-actuator) without spacer;   Drug: Mometasone Furoate/Formoterol Fumarate MDI (ex-actuator) with spacer;   Drug: Placebo MDI with spacer;   Drug: Placebo MDI without spacer;   Drug: Mometasone Furoate DPI
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Mon, 13 Dec 2010 12:00:00 EST

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Condition:   Asthma
Interventions:   Drug: QMF149 Twisthaler®;   Drug: Mometasone Twisthaler®
Sponsor:   Novartis Pharmaceuticals
Completed

Mon, 20 Jul 2009 12:00:00 EDT

Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma

Condition:   Asthma
Interventions:   Drug: Mometasone furoate;   Device: Concept 1;   Device: Twisthaler
Sponsor:   Novartis Pharmaceuticals
Completed

Thu, 15 Mar 2012 12:00:00 EDT

Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma

Condition:   Asthma
Interventions:   Drug: indacaterol maleate/mometasone furoate;   Drug: placebo to indacaterol maleate/mometasone furoate;   Drug: fluticasone proprionate / salmeterol xinafoate
Sponsors:   Novartis;   Merck Sharp & Dohme Corp.
Completed

Mon, 12 Nov 2007 12:00:00 EST

Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma

Condition:   Asthma
Interventions:   Drug: indacaterol maleate / mometasone furoate;   Drug: placebo to indacaterol maleate/mometasone furoate
Sponsors:   Novartis;   Merck Sharp & Dohme Corp.
Completed

Thu, 31 Jan 2008 12:00:00 EST

Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent Asthma

Condition:   Asthma
Interventions:   Drug: fluticasone propionate/salmeterol;   Drug: indacaterol maleate / mometasone furoate;   Drug: placebo to indacaterol/mometasone;   Drug: placebo to fluticasone propionate/salmeterol
Sponsor:   Novartis
Completed

Wed, 14 Nov 2007 12:00:00 EST

Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma

Condition:   Mild Asthma
Interventions:   Drug: QMF149 150/80 μg;   Drug: MF 200 μg
Sponsor:   Novartis Pharmaceuticals
Completed

Thu, 08 Sep 2016 12:00:00 EDT

Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma

Condition:   Asthma
Interventions:   Drug: Mometasone furoate;   Drug: QMF149
Sponsor:   Novartis Pharmaceuticals
Recruiting

Mon, 19 Oct 2020 12:00:00 EDT